DaVita CCO trims 8% stake in pre-planned trade

Rhea-AI Filing Summary

DaVita Inc. (DVA) Form 4: Chief Compliance Officer James O. Hearty sold 2,351 common shares on 07/23/2025 at $150.00 each under a pre-arranged Rule 10b5-1 trading plan adopted 03/17/2025. The transaction reduced his direct holdings from an estimated 28,389 to 26,038 shares, a decline of roughly 8.3%. No derivative securities were involved. The filing was signed by an attorney-in-fact on 07/24/2025.

The sale represents a modest portion of the insider’s stake and was executed via an automated plan, which may limit informational value regarding management’s outlook. Investors typically monitor insider activity for sentiment signals, trading-plan usage, and potential supply impacts on the stock’s float.

Positive

• Sale executed under a Rule 10b5-1 plan, suggesting it was pre-scheduled and not necessarily driven by near-term corporate outlook.

Negative

• Insider reduced holdings by ~8%, which may be interpreted as modestly bearish sentiment.

Insights

Insider-Transaction Analyst

TL;DR: Small, plan-based insider sale; limited negative signal.

The 2,351-share sale equates to about 8% of Hearty’s direct position and <0.03% of DaVita’s float, so liquidity impact is negligible. Rule 10b5-1 usage reduces signaling risk because trades were scheduled in advance, but continued trimming can still be perceived as mild bearishness. Overall, I view the filing as neutral-to-slightly negative for sentiment, with minimal financial impact on DVA.

Portfolio Manager

TL;DR: Transaction immaterial for valuation; watch pattern.

From a portfolio standpoint, the dollar value (~$0.35 m) and share count are too small to alter supply–demand dynamics or earnings trajectory. However, if cumulative insider sales accelerate, it could weigh on multiples. I classify this event as not impactful for position sizing but will monitor future Form 4s for trend confirmation.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

HEARTY JAMES O

(Last) (First) (Middle)

C/O DAVITA INC.

2000 16TH STREET

(Street)

DENVER CO 80202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DAVITA INC. [ DVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Compliance Officer

3. Date of Earliest Transaction (Month/Day/Year)
07/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/23/2025		S		2,351	D	$150	26,038	D(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2025.

Remarks:

	/s/ Stephanie Berberich, Attorney-in-Fact	07/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many DaVita (DVA) shares did James O. Hearty sell?

He sold 2,351 common shares on 07/23/2025.

At what price were the DVA shares sold?

The shares were sold at $150.00 each.

What is James O. Hearty’s remaining share ownership after the sale?

He now directly owns 26,038 shares of DaVita common stock.

Was the transaction part of a trading plan?

Yes, it was executed under a Rule 10b5-1 plan adopted on 03/17/2025.

Does the Form 4 include any derivative security activity?

No, no derivative securities were reported in this filing.